Moderna Inc. buy Barclays PLC
Start price
16.09.24
/
50%
€62.07
Target price
16.09.25
€112.33
Performance (%)
-65.73%
End price
17.09.25
€21.27
Summary
This prediction ended on 17.09.25 with a price of €21.27. The BUY prediction by Barclays_PLC for Moderna Inc. performed very badly with a performance of -65.73%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 5.571% | 5.571% | -37.005% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Barclays_PLC for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $155.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten